Results 31 to 40 of about 14,646 (214)

Metalloprotein‐based MRI probes [PDF]

open access: yesFEBS Letters, 2013
Metalloproteins have long been recognized as key determinants of endogenous contrast in magnetic resonance imaging (MRI) of biological subjects. More recently, both natural and engineered metalloproteins have been harnessed as biotechnological tools to probe gene expression, enzyme activity, and analyte concentrations by MRI.
Matsumoto, Yuri, Jasanoff, Alan Pradip
openaire   +4 more sources

Electron Flow through Metalloproteins [PDF]

open access: yesChemical Reviews, 2010
Electron transfers in photosynthesis and respiration commonly occur between metal-containing cofactors that are separated by large molecular distances. Understanding the underlying physics and chemistry of these biological electron transfer processes is the goal of much of the work in our laboratories.
Gray, Harry B., Winkler, Jay R.
openaire   +5 more sources

Finding High-Quality Metal Ion-Centric Regions Across the Worldwide Protein Data Bank

open access: yesMolecules, 2019
As the number of macromolecular structures in the worldwide Protein Data Bank (wwPDB) continues to grow rapidly, more attention is being paid to the quality of its data, especially for use in aggregated structural and dynamics analyses. In this study, we
Sen Yao, Hunter N.B. Moseley
doaj   +1 more source

Functional analysis of the citrate activator CitO from Enterococcus faecalis implicates a divalent metal in ligand binding

open access: yesFrontiers in Microbiology, 2016
The regulator of citrate metabolism, CitO, from Enterococcus faecalis belongs to the FCD family within the GntR superfamily. In the presence of citrate, CitO binds to cis-acting sequences located upstream of the cit promoters inducing the expression of ...
Victor S. Blancato   +5 more
doaj   +1 more source

RPL6: A Key Molecule Regulating Zinc- and Magnesium-Bound Metalloproteins of Parkinson’s Disease

open access: yesFrontiers in Neuroscience, 2021
Parkinson’s disease (PD) is a progressive neurodegenerative disease with no definite molecular markers for diagnosis. Metal exposure may alter cellular proteins that contribute to PD.
Athira Anirudhan   +7 more
doaj   +1 more source

Zinc Gluconate in the Treatment of Dysgeusia—a Randomized Clinical Trial [PDF]

open access: yes, 2005
In the treatment of dysgeusia, the use of zinc has been frequently tried, with equivocal results. The aim of the present randomized clinical trial, which involved a sufficiently large sample, was therefore to determine the efficacy of zinc treatment ...
Friess, Wolfgang   +6 more
core   +1 more source

Machine learning differentiates enzymatic and non-enzymatic metals in proteins

open access: yesNature Communications, 2021
The authors generate the largest structural dataset of enzymatic and non-enzymatic metalloprotein sites to date. They use this dataset to train a decision-tree ensemble machine learning algorithm that allows them to distinguish between catalytic and non ...
Ryan Feehan   +2 more
doaj   +1 more source

Correlation between relaxometry and diffusion tensor imaging in the globus pallidus of Huntington's disease patients. [PDF]

open access: yesPLoS ONE, 2015
Huntington's disease (HD) is an inherited neurodegenerative disorder with progressive impairment of motor, behavioral and cognitive functions. The clinical features of HD are closely related to the degeneration of the basal ganglia, predominantly the ...
Michael Syka   +7 more
doaj   +1 more source

Serum levels of matrix metalloproteinases-2 and-9 and their tissue inhibitors in inflammatory neuromuscular disorders [PDF]

open access: yes, 2006
We monitored serum levels of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) before and during intravenously applied immunoglobulin (IVIG) therapy in 33 patients with chronic immune-mediated neuropathies and myopathies and 15 ...
B.G.H. Schoser   +15 more
core   +1 more source

Dihydropyrimidine-thiones and clioquinol synergize to target beta-amyloid cellular pathologies through a metal-dependent mechanism [PDF]

open access: yes, 2017
The lack of therapies for neurodegenerative diseases arises from our incomplete understanding of their underlying cellular toxicities and the limited number of predictive model systems.
Barrasa, M. Inmaculada   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy